These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19844216)

  • 21. Optimizing drug development and use in patients with kidney disease.
    Nolin TD; Arya V; Sitar DS; Pfister M
    J Clin Pharmacol; 2011 May; 51(5):628-30. PubMed ID: 21525394
    [No Abstract]   [Full Text] [Related]  

  • 22. Understanding the mechanisms of adverse drug reactions.
    Bhatt AD; Sane SP; Vaidya AB
    J Assoc Physicians India; 1994 Feb; 42(2):132-4, 139-41. PubMed ID: 7860475
    [No Abstract]   [Full Text] [Related]  

  • 23. [Adverse reactions to drugs in pediatric medicine. A point of view].
    Vargas-Rivera J; Sumano-López H
    Bol Med Hosp Infant Mex; 1992 May; 49(5):316-9. PubMed ID: 1605881
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Confounding factors for sex differences in pharmacokinetics and pharmacodynamics: focus on dosing regimen, dosage form, and formulation.
    Chen ML
    Clin Pharmacol Ther; 2005 Oct; 78(4):322-9. PubMed ID: 16198651
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics tricks and traps: drug dosage adjustment in renal failure.
    Boxenbaum H; Tannenbaum S; Mayersohn M; Oleson F
    J Pharm Pharm Sci; 1999; 2(1):2-4. PubMed ID: 10951656
    [No Abstract]   [Full Text] [Related]  

  • 26. The role of binding kinetics in therapeutically useful drug action.
    Swinney DC
    Curr Opin Drug Discov Devel; 2009 Jan; 12(1):31-9. PubMed ID: 19152211
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An outlook on pharmacokinetics in chemotherapy.
    Otaya H
    Int J Clin Pharmacol Biopharm; 1978 Sep; 16(9):430-2. PubMed ID: 700916
    [No Abstract]   [Full Text] [Related]  

  • 28. American College of Clinical Pharmacology position statement on the use of microdosing in the drug development process.
    Bertino JS; Greenberg HE; Reed MD;
    J Clin Pharmacol; 2007 Apr; 47(4):418-22. PubMed ID: 17389550
    [No Abstract]   [Full Text] [Related]  

  • 29. [Principles of drug therapy. Pharmacokinetics].
    MMW Munch Med Wochenschr; 1979 Jul; 121(27):suppl 18-9. PubMed ID: 112440
    [No Abstract]   [Full Text] [Related]  

  • 30. [Precautions in use of drugs for elderly patients].
    Mikami H
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():42-7. PubMed ID: 18074515
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pharmacokinetics and compartmental analysis].
    Grégoire F
    J Pharm Belg; 1972; 27(5):631-47. PubMed ID: 4660651
    [No Abstract]   [Full Text] [Related]  

  • 32. Drug dosage adjustments in diseased patients.
    Jusko WJ
    Ration Drug Ther; 1976 Jun; 10(6):1-7. PubMed ID: 951505
    [No Abstract]   [Full Text] [Related]  

  • 33. Emerging evidence of the impact of kidney disease on drug metabolism and transport.
    Nolin TD; Naud J; Leblond FA; Pichette V
    Clin Pharmacol Ther; 2008 Jun; 83(6):898-903. PubMed ID: 18388866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Tobacco smoking and drug interactions].
    Molden E; Spigset O
    Tidsskr Nor Laegeforen; 2009 Mar; 129(7):632-3. PubMed ID: 19337332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacogenetics.
    Carnes M
    N Engl J Med; 2003 May; 348(20):2041-3; author reply 2041-3. PubMed ID: 12751474
    [No Abstract]   [Full Text] [Related]  

  • 36. [Precautions in use of drugs for Infants and children].
    Bamba M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():29-33. PubMed ID: 18074513
    [No Abstract]   [Full Text] [Related]  

  • 37. Why can't a woman be more like a man?
    Gray J
    Clin Pharmacol Ther; 2007 Jul; 82(1):15-7. PubMed ID: 17571069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenetics.
    Padrini R; Ferrari M
    N Engl J Med; 2003 May; 348(20):2041-3; author reply 2041-3. PubMed ID: 12748327
    [No Abstract]   [Full Text] [Related]  

  • 39. [Disorders of pharmacokinetics in pathological states and their clinical significance].
    Orzechowska-Juzwenko K; Bolanowski M; Janicki AG
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1681-6. PubMed ID: 6522322
    [No Abstract]   [Full Text] [Related]  

  • 40. [Drug dosage optimization taking into account human circadian rhythms].
    Kudrin AN; Davydova ON; Zatsepilova TA; Riazhenov VV
    Sov Med; 1985; (10):37-41. PubMed ID: 3909447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.